mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |